Wilson Wolf Manufacturing, LLC
New Brighton, MN
- UEI
- L1HKPVNJ33J8
- CAGE
- 47J39
- Primary NAICS
- 339112 Surgical and Medical Instrument Manufacturing
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Partnership or Limited Liability Partnership
- Other NAICS codes in SAM.gov
- SAM.gov registration date
- Physical address
- 2100 Old Hwy 8 NW, New Brighton, MN 55112, USA
- Website
- wilsonwolf.com
- Founded
- 1998
- Employees
- 11-50
- Estimated annual revenue
- $1M-$10M
- Industry
-
- Health Care
- Health Care Equipment & Services
- Health Care Providers & Services
- SIC code
- 38 Instruments & Related Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract obligations by fiscal year
| Fiscal year | Obligated |
|---|---|
| FY2027 To date | $0 |
| FY2026 | $431,897 |
| FY2025 | -$83,982 |
| FY2024 | $688,172 |
| FY2023 | $42,532 |
Top agencies by obligations
| Rank | Agency | Obligated, FY2026–FY2027 | Share |
|---|---|---|---|
| 1 | Department of Health and Human Services | $431,897 |
Contract awards
Latest 5 listed here. See the rest on GovTribe.
Grant awards
Similar vendors
| Vendor | Location | Primary NAICS |
|---|---|---|
| Miltenyi Biotec, Inc. | Auburn, CA | 334516 Analytical Laboratory Instrument Manufacturing |
| Link Biosystems Inc. | Irvington, NY | 541714 Research and Development in Biotechnology (except Nanobiotechnology) |
| Scientific Bioprocessing, Inc. | Bohemia, NY | 334516 Analytical Laboratory Instrument Manufacturing |
| Cell Microsystems Inc. | Durham, NC | 334516 Analytical Laboratory Instrument Manufacturing |
| Infors USA Inc. | Annapolis Junction, MD | 334516 Analytical Laboratory Instrument Manufacturing |
About the company
Wilson Wolf Manufacturing, LLC, operating as Wilson Wolf, manufactures specialized cell culture devices and bioreactors for federal research and clinical applications, supplying these goods exclusively as a prime contractor to the National Institutes of Health and the National Cancer Institute. The company is a self-certified small disadvantaged business based in Mounds View, Minnesota, structured as a limited liability partnership and manufacturer of goods, competing in full-and-open procurements with no set-aside designations applied to recent awards.
Wilson Wolf's federal capability centers on G-REX series gas-permeable cell culture devices and G-REX500M bioreactors that enable FDA-regulated cell-based therapy manufacturing supporting cancer treatment and clinical trials. The company holds sole-source authority on certain validated bioreactor models — the NIH Clinical Center's Center for Cellular Engineering has approved Wilson Wolf's equipment as the only known source capable of providing validated G-REX500M bioreactors meeting government requirements for cell therapy manufacturing, with substitution requiring extensive requalification testing and unacceptable delays to patient care timelines. Representative work includes a $699,861 firm fixed-price purchase order from the National Cancer Institute for G-REX cell culture products supporting the Surgery Branch's adoptive cell therapy program (awarded July 2024, completion July 2026); two consecutive sole-source purchase orders from the NIH Clinical Center in July and August 2026 for G-REX500M bioreactors valued at $53,711 and $38,378, respectively; and a $339,826 purchase order from the National Cancer Institute for G-REX100 cell culture devices (3-pack configuration) awarded August 2026.
Customer concentration is extreme. The National Cancer Institute accounts for 29 awards and $5.2 million in combined potential value (84% of the vendor's total), while the NIH Clinical Center holds 21 awards and $941 thousand combined potential value. Together, these two entities represent 98% of all awards in the source data. The NIH Office of the Chief Operating Officer, the NIH itself, and the National Heart Lung and Blood Institute round out six distinct customer agencies. The vendor operates under a single indefinite delivery contract vehicle, HHSN261201200040I, with four task orders placing $1.1 million in combined potential value. Recent activity is sparse — three awards in 2024, two in 2023, and three in 2026 — with only one award (the August 2026 NCI G-REX100 purchase order valued at $339,826) reaching ultimate completion within the next twenty-four months. The vendor holds 64 prime awards across 22 years of federal contracting with no subcontract footprint; combined obligated dollars ($11.9 million) exceed combined potential value ($6.2 million), indicating systematic invoice of prior-year obligations. Top NAICS categories are Analytical Laboratory Instrument Manufacturing (17 awards), Biological Product Manufacturing (14 awards), and Surgical and Medical Instrument Manufacturing (14 awards), with top PSC codes reflecting laboratory equipment and supplies (39 awards) and drugs and biologicals (16 awards).
Quick answers
Is Wilson Wolf Manufacturing, LLC registered in SAM.gov?
Yes. Wilson Wolf Manufacturing, LLC's SAM.gov registration is active through January 19, 2027.
How much has Wilson Wolf Manufacturing, LLC received in federal contracts?
Federal contracts obligated $1,078,620 to Wilson Wolf Manufacturing, LLC in fiscal years 2023 through 2027.
What is Wilson Wolf Manufacturing, LLC's most recent federal award?
Wilson Wolf Manufacturing, LLC's most recent federal contract award is NCI - g-REX100 (3-pack box) (75N98026P01461), from Office of Logisitics and Acquisition Operations (NIH), on August 27, 2026.
On GovTribe
See Wilson Wolf Manufacturing, LLC's full federal record
- Federal contract awards
- IDV awards
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors